Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07127354 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 4, 2025 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Phase: Not applicable to Phase 4v2 Show 4 more changesShow less
    • Enrollment target: 120 to 132
    • Study sites: 2 to 3
    • Start date changed from estimate of Aug 2025 to Aug 1, 2025
    • Secondary endpoints: details revised at 7 of 9 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn how GLP-1 and GIP agonists effect bowel preparation in patients scheduled for colonoscopies. The main questions it aims to answer are: * Does GLP-1 and GIP agonist increase the rate of inadequate bowel preparation? * Does the quality of bowel preparation differ in patients who hold vs. those who continue a single dose of their GLP-1 or GIP agonist medication? * Are there any differences in the rates of complications gastric aspiration in patients who hold vs. continue a single dose of their GLP-1 or GIP agonist medication?
Trial Details
NCT Number NCT07127354
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 GLP - 1, Bowel Preparation for Colonoscopy
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov